Prices as of 2026/10/30 close
Company comparison
GMO is the bigger company, with revenue of ¥285.3B — 7.0x DG's ¥41.0B.
Revenue growth in the latest results: DG +7.0%, GMO +3.3%.
DG pays more on average — ¥8.50M against ¥6.93M at GMO.
Over the past year the shares moved GMO −4.2%, DG −24.2%.
Head-to-head wins11 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
GMO aheadGMO 2 : DG 0
Revenue: GMO ¥285.3B / DG ¥41.0B
ProfitabilityInvestors
GMO aheadGMO 2 : DG 0
Net margin: GMO 12.9% / DG 3.1%
GrowthInvestors
DG aheadGMO 0 : DG 1
Revenue growth (YoY): GMO +3.3% / DG +7.0%
Stock & balance sheetInvestors
DG aheadGMO 1 : DG 2
Share price, 1 year: GMO −4.2% / DG −24.2%
Pay & workforceJob seekers
GMO aheadGMO 2 : DG 1
Average salary: GMO ¥6.93M / DG ¥8.50M
| Metric | GMO | DG | Gap |
|---|---|---|---|
| Revenue | ◎¥285.3B | ¥41.0B | 7.0x |
| Operating profit | ¥59.1B | — | |
| Net income | ◎¥36.7B | ¥1.3B | 28.6x |
| Metric | GMO | DG | Gap |
|---|---|---|---|
| Operating margin | 20.7% | — | |
| Net margin | ◎12.9% | 3.1% | 9.7pt |
| ROE | — | 1.7% | |
| Revenue per employee | ◎¥395M | ¥74M | 5.4x |
| Metric | GMO | DG | Gap |
|---|---|---|---|
| Revenue growth (YoY) | +3.3% | ◎+7.0% | 3.7pt |
| Operating profit growth (YoY) | +19.5% | — | |
| Revenue CAGRlast 4 years | +4.2% | — |
| Metric | GMO | DG | Gap |
|---|---|---|---|
| Share price, 1 year | ◎−4.2% | −24.2% | 20.0pt |
| Share price, 3 months | −22.9% | ◎−3.1% | 19.7pt |
| P/E (trailing)lower = cheaper | 19.8x | 86.1x | |
| Equity ratio | 11.8% | ◎35.5% | 23.7pt |
| Share price (close) | ¥3,248 | ¥2,406 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | GMO | DG | Gap |
|---|---|---|---|
| Average salary | ¥6.93M | ◎¥8.50M | ¥1.56M |
| Starting salary (monthly) | ◎¥591,667 | ¥333,342 | ¥258,325 |
| Average tenure | ◎8.2 yrs | 5.8 yrs | 2.4 |
| Average age | 37.9 | 39.7 | 1.8 |
| Employees | 723 | 557 | 1.3x |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥3,248-4.2% (1Y)
GMO -4.2% over 1Y. Compared: DG -24.2%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
GMO5 segments
DG3 segments
AAverage annual salary from the securities filings: DG ¥8.50M, GMO ¥6.93M. DG pays the most. Averages also depend on staff age and job mix, so check the average age too (GMO 37.9, DG 39.7).
ARevenue in the latest results: GMO ¥285.3B, DG ¥41.0B. GMO is the bigger company, with revenue of ¥285.3B — 7.0x DG's ¥41.0B.
AShare price change over the past year (closing prices, for reference): GMO −4.2%, DG −24.2%. GMO has risen the most.
Comparing 2 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.
